Summary
Regulation of aldosterone secretion by sodium chloride is impaired in a group of essential hypertensives: high-salt diet fails to suppress aldosterone in these patients despite low renin values. The mechanism of this impaired regulation of aldosterone has not been clarified so far. We tested the sensitivity of aldosterone secretion and blood pressure to A II in 20 normotensive controls (aged 20–60, MAP 92±3 mm Hg), in ten normotensives with one or two parents with hypertension, and in 21 patients with essential hypertension (aged 17–65, MAP 119±4 mm Hg). After a period of 6 days on high-salt intake (300–320 mEq Na+/day), A II (0.1, 0.5, 1.0 and 2.0 ng/kg/min) was infused, each concentration for 30 min. According to aldosterone excretion during sodium loading, patients were divided into group A with complete suppression (n=12, aldosterone excretion 3.6±0.4 µg/day) and in group B with insufficient suppression (n=9, aldosterone excretion 15.5±2.3 µg/day). Despite similarly low plasma renins, rise of serum aldosterone levels during A II infusion was significantly higher in group B patients than in group A patients and normotensive controls. Rise in mean arterial blood pressure, however, brought about by graded A II infusion was similar in both groups of hypertensives and in normotensive controls. The results demonstrate an increased adrenal sensitivity to A II in a subgroup of essential hypertensives only. A similar adrenal hypersensitivity to A II found by others in patients with hyperaldosteronism due to adrenal hyperplasia supports the hypothesis that the same mechanism underlies both disorders.
Similar content being viewed by others
Abbreviations
- MAP:
-
mean arterial blood pressure
- A II:
-
Angiotensin II
References
Fraser R, Beretta Piccoli C, Brown JJ, Cumming AM, Lever AF, Mason DA, Morton JJ, Robertson JJS (1981) Response of aldosterone and 18-Hydroxycorticosterone to Angiotensin II in normal subjects and patients with essential hypertension. Conn's syndrome and nontumorous hyperaldosteronism. Hypertension 3 (Suppl I):I 87-I 92
Helber A, Kaufmann W (1973) Radioimmunologische Methode zur Aldosteronbestimmung im Urin. Klin Wochenschr 51:1164–1169
Helber A, Meurer KA, Rosskamp E, Wambach G, Dickmans HA, Kaufmann W (1974) Aldosteronexkretion und Plasmareninaktivität von Patienten mit essentieller Hypertonie und mit reninsupprimiertem Hyperaldosteronismus. Klin Wochenschr 52:966
Helber A, Wambach G, Hummerich W, Bönner G, Meurer KA, Kaufmann W (1980) Evidence for a subgroup of essential hypertensives with inadequate excretion of aldosterone during sodium loading. Klin Wochenschr 58:439–447
Hummerich W, Krause DK (1975) Improvement of Renin Determination in Human Plasma using a commonly available Renin Standard in a Radioimmunological Method. Klin Wochenschr 53:559–569
Kisch ES, Dluhy RG, Williams GH (1976) Enhanced aldosterone response to angiotensin II in human hypertension. Circ Res 38:502–505
Kloppenburg PWC, Drayer JIM, Benraad HB, Benraad ThJ (1974) Normal aldosterone versus supranormal aldosterone hypertension: An alternative to normal renin versus low renin hypertension. In: Distler, Wolff (eds) Current problems in hypertension. Thieme, Stuttgart, p 143
Luetscher JA, Beckerhoff R, Dowdy, AJ, Wilkinson R (1972) Incomplete suppression of aldosterone secretion and plasma concentration in hypertensive patients on high sodium intake. In: Genest, Koiw (eds) Hypertension 72. Springer, Berlin Heidelberg New York, p 286
Marks AD, Marks DB, Kanefsky TM, Adlin VE, Channik BJ (1979) Enhanced adrenal responsiveness to Angiotensin II in patients with low renin essential hypertension. J Clin Endocrinol Metab 48:266–270
Oelkers W, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JIS (1974) Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res 34:69–77
Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore ThJ, Dluhy RG (1983) Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab 57:764–770
Takeda R, Morimoto Sh, Uchida K, Miyamori I, Hashiba T (1980) Effect of age on plasma aldosterone response to exogenous angiotensin II in normotensive subjects. Acta Endocrinol (Kbh) 94:552–558
Taylor T, Moore ThJ, Hollenberg NK, Williams GH (1984) Converting enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension. Hypertension 6:92–99
Wambach G, Helber A, Bönner G, Konrads A, Hummerich W, Meurer KA, Kaufmann W (1982) Characterization of a group of essential hypertensives with impaired regulation of aldosterone. Clin Exp Hypertension A 4:1835–1849
Williams GH, Tuck ML, Sullivan JM, Dluhy RG, Hollenberg NK (1982) Parallel adrenal and renal abnormalities in young patients with essential hypertension. Am J Med 72:907–914
Wisgerhoff M, Brown RD (1978) Increased adrenal sensitivity to angiotensin II in low renin essential hypertension. J Clin Invest 61:1456
Wisgerhoff M, Brown RD, Hogen MJ, Carpenter PC, Edis AJ (1981) The plasma aldosterone response to Angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52:195–198
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr. W. Kaufmann on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Wambach, G., Meiners, U., Bönner, G. et al. Cardiovascular and adrenal sensitivity to angiotensin II in essential hypertension. Klin Wochenschr 62, 1097–1101 (1984). https://doi.org/10.1007/BF01782465
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01782465